Erratum: Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage (Stroke (2012) DOI: 10.1161/STROKEAHA));The alphabet of imaging in acute stroke does it spell improved selection and outcome?

Stroke

Volumn 44, Issue SUPPL. 1, 2013, Pages

  Rowley, Howard A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Brain perfusion; CT; MRI; Stroke; Thrombolysis

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ATHEROSCLEROTIC PLAQUE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DEVICE THERAPY; HEALTH CARE COST; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 84880268780     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STR.0b013e3182673a71     Document Type: Erratum

References (7)

1. Adeoye O, Hornung R, Khatri P, Kleindorfer D. Recombinant tissuetype plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42:1952-1955.
2. Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL. Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke. 2009;40:2079-2084.
3. Salottolo KM, Fanale CV, Leonard KA, Frei DF, Bar-Or D. Multimodal imaging does not delay intravenous thrombolytic therapy in acute stroke. AJNR Am J Neuroradiol. 2011;32:864-868.
4. Kim AS, Nguyen-Huynh M, Johnston SC. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke. 2011;42:2013-2018.
5. Nguyen-Huynh MN, Johnston SC. Is mechanical clot removal or disruption a cost-effective treatment for acute stroke? AJNR Am J Neuroradiol. 2011;32:244-249.
6. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 Study Investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
7. Saver JL, Smith EE, Fonarow GC, Reeves MJ, Zhao X, Olson DM, et al GWTG-Stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30,000 patients arriving within 60 minutes of stroke onset. Stroke. 2010;41:1431-1439.